Načítá se...
Blinding in Clinical Trials: Seeing the Big Picture
Blinding mitigates several sources of bias which, if left unchecked, can quantitively affect study outcomes. Blinding remains under-utilized, particularly in non-pharmaceutical clinical trials, but is often highly feasible through simple measures. Although blinding is generally viewed as an effectiv...
Uloženo v:
| Vydáno v: | Medicina (Kaunas) |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8308085/ https://ncbi.nlm.nih.gov/pubmed/34202486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57070647 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|